# Pharmacologic Augmentation of TMS for Depression With D-serine

> **NCT06876129** · PHASE1 · RECRUITING · sponsor: **Mclean Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Depression

## Interventions

- **DEVICE:** TMS
- **DRUG:** D-serine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06876129
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-12-26
- **Final completion:** 2027-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06876129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06876129, "Pharmacologic Augmentation of TMS for Depression With D-serine". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06876129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*